Form 4: Chemours Executive Calderon Gerardo Reports Stock Transaction
SEC Form 4 Filing
Gerardo Calderon, a Chemours executive, reported a transaction involving the withholding of shares to cover tax obligations on vested stock units.
Summary
- On August 1, 2024, Gerardo Calderon, President of Advanced Performance Materials at Chemours, reported a transaction.
- The transaction involved the withholding of 876 common stock shares at a price of $23.31 to satisfy tax obligations on vesting restricted stock units and dividend equivalent units.
- Following the transaction, Calderon directly owns 23,054.283 shares of Chemours common stock, including directly owned shares, restricted stock units, and dividend equivalent units.
- The transaction was exempt from Section 16(b) pursuant to Rule 16b-3, and no shares were sold.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing related to insider stock transactions. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard corporate governance and transparency. The score is neutral to slightly positive due to the transparency.
Industry Context
This is a routine Form 4 filing, which is standard practice when company insiders engage in transactions involving the company's stock. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax-related withholding of shares.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Date of the stock transaction (withholding of shares). |
| 08/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.